Day: March 17, 2022

CORRECTION - Badger Infrastructure Solutions Ltd. Announces 2021 Fourth Quarter and Annual Financial Results and a Dividend Increase

CORRECTION – Badger Infrastructure Solutions Ltd. Announces 2021 Fourth Quarter and Annual Financial Results and a Dividend Increase

CALGARY, Alberta, March 17, 2022 (GLOBE NEWSWIRE) — In a release issued earlier today by Badger Infrastructure Solutions Ltd. (TSX:BDGI) please note that all references to the normal course issuer bid have been excised. The corrected release follows: Badger Infrastructure Solutions Ltd. (“Badger”, the “Company”, “we”, “our” or “us”) (TSX:BDGI) reported fourth quarter and annual 2021 results today. All results are presented in Canadian dollars unless otherwise stated. 2021 Fourth Quarter and Annual Financial and Operational Highlights Revenue in the quarter was $152.9 million and $568.8 million for the year, up 17.1% and 1.8% respectively from 2020. Gross profit margin in the quarter was 19.0% and 20.9% for the year, compared with 24.1% and 29.4% respectively in 2020. Adjusted EBITDA in the quarter was $16.8 million and $72.5 million...

Continue reading

Nutriterra® Clinical Trial Published by Frontiers in Nutrition, Results Demonstrate Efficacy of Plant-Based Total Omega-3

Nutriterra® Clinical Trial Published by Frontiers in Nutrition, Results Demonstrate Efficacy of Plant-Based Total Omega-3

Peer reviewed human clinical trial confirms the safety and efficacy of Nutriterra®, a novel plant-based source of seven omega-3 fatty acids. Nutriterra Total Omega-3 Plant-Based Total Omega-3 Capsule Nutriterra and Ocean of Nutrition Nutriterra supports human health and ocean habitats West Sacramento, March 17, 2022 (GLOBE NEWSWIRE) — Nuseed Nutritional US Inc., (nuseed.com) conducted a human clinical trial confirming the safety and efficacy of Nutriterra® as a novel plant-based source of seven omega-3 fatty acids. Frontiers in Nutrition, a leading peer-reviewed scientific journal, published the results of this research after a thorough evaluation of the study. Nuseed Nutritional welcomes this validation of Nutriterra as a sustainable, non-marine source of essential fatty acids. Nutriterra is the world’s first land-based source...

Continue reading

Badger Infrastructure Solutions Ltd. Announces 2021 Fourth Quarter and Annual Financial Results, a Dividend Increase and a Normal Course Issuer Bid

Badger Infrastructure Solutions Ltd. Announces 2021 Fourth Quarter and Annual Financial Results, a Dividend Increase and a Normal Course Issuer Bid

CALGARY, Alberta, March 17, 2022 (GLOBE NEWSWIRE) — Badger Infrastructure Solutions Ltd. (“Badger”, the “Company”, “we”, “our” or “us”) (TSX:BDGI) reported fourth quarter and annual 2021 results today. All results are presented in Canadian dollars unless otherwise stated. 2021 Fourth Quarter and Annual Financial and Operational Highlights Revenue in the quarter was $152.9 million and $568.8 million for the year, up 17.1% and 1.8% respectively from 2020. Gross profit margin in the quarter was 19.0% and 20.9% for the year, compared with 24.1% and 29.4% respectively in 2020. Adjusted EBITDA in the quarter was $16.8 million and $72.5 million for the year, compared with $22.0 million and $122.8 million respectively in 2020. Adjusted EBITDA margin in the quarter was 11.0% and 12.7% for the year, compared with 16.8% and 22.0% respectively...

Continue reading

Global Crossing Airlines Announces US$6.0 million Financing

Global Crossing Airlines Announces US$6.0 million Financing

MIAMI, March 17, 2022 (GLOBE NEWSWIRE) — Global Crossing Airlines Group, Inc. (JET: NEO; JET.B: NEO; JETMF: OTCQB) (the “Company” or “GlobalX”) is pleased to announce a US$6.0 million offering of non-convertible debentures (the “Offering”). The lead investor in the Offering is Alterna Capital Partners LLC (“Alterna”), through an affiliate of Alterna Core Capital Assets Fund II, L.P., with a US$2.5 million commitment. Alterna is a real asset investor with a specific focus on transportation assets. The investment represents Alterna’s commitment to support GlobalX with its growth strategy and is made in conjunction with various leasing partnerships. Alterna was founded in 2007 and currently manages over US$600 million across two private equity funds, one credit fund and co-investments. The Offering will consist of non-convertible...

Continue reading

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Fluidigm Stockholders Vote “FOR” ALL Proposals Related to $250 Million Strategic Capital Infusion

Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Fluidigm Stockholders Vote “FOR” ALL Proposals Related to $250 Million Strategic Capital Infusion

Fluidigm Board of Directors Unanimously Recommends Stockholders Vote “FOR” ALL Proposals TODAY SOUTH SAN FRANCISCO, Calif., March 17, 2022 (GLOBE NEWSWIRE) — Fluidigm Corporation (NASDAQ:FLDM), today announced that leading independent proxy advisory firms Institutional Shareholder Services (“ISS”) and Glass, Lewis & Co. (“Glass Lewis”) have recommended that Fluidigm stockholders vote “FOR” ALL proposals related to the previously announced strategic capital infusion from leading life sciences and biotechnology-focused investors Casdin Capital, LLC (“Casdin”) and Viking Global Investors LP (“Viking”) at the Company’s upcoming Special Meeting of Stockholders (the “Special Meeting”) scheduled for March 25, 2022. In its March 8, 2022 report, ISS stated1, “A vote FOR the proposal is warranted… [T]here is substantial doubt regarding...

Continue reading

Kimball International, Inc. to Present at the Sidoti Spring 2022 Virtual Small Cap Conference

Kimball International, Inc. to Present at the Sidoti Spring 2022 Virtual Small Cap Conference

JASPER, Ind., March 17, 2022 (GLOBE NEWSWIRE) — Kimball International, Inc. (NASDAQ: KBAL) announced its participation in the Sidoti Spring 2022 Virtual Small Cap Conference. Chief Executive Officer Kristine Juster and Chief Financial Officer T.J. Wolfe will present at 10:45 a.m. Eastern Time on Wednesday, March 23. A live audio webcast of the presentation will be available here. A replay will be available for three months following the conference. About Kimball International, Inc. Kimball International is a leading omnichannel commercial furnishings company with deep expertise in the Workplace, Health, and Hospitality markets. We combine our bold entrepreneurial spirit, a history of craftsmanship and today’s design-driven thinking alongside a commitment to our culture of caring and lasting connections with our customers, shareholders,...

Continue reading

Grupo Aeroportuario del Pacifico Announces Issuance of Bond Certificates in Mexico for PS. 5.0 Billion

Grupo Aeroportuario del Pacifico Announces Issuance of Bond Certificates in Mexico for PS. 5.0 Billion

GUADALAJARA, Mexico, March 17, 2022 (GLOBE NEWSWIRE) — Grupo Aeroportuario del Pacífico, S.A.B. de C.V., (NYSE: PAC; BMV: GAP) (the “Company” or “GAP”) announced today that it successfully completed the issuance of 50 million long-term bond certificates in Mexico (Certificados Bursátiles) at a nominal value of Ps. 100 each (One hundred pesos 00/100), for a total value of Ps. 5.0 billion, through a dual tranche strategy. The amount of the issuance was up to Ps. 4.0 billion with a greenshoe option of Ps. 1.0 billion, which was reached at the closing of the issuance. The order book reached an over-subscription of 4.04x. The bond certificates were issued in accordance with the following terms: 20 million 5-year bond certificates were issued under the ticker symbol “GAP22”, at a nominal value of Ps. 100 (One hundred pesos 00/100) each,...

Continue reading

Marker Therapeutics Reports Fiscal Year 2021 Operating and Financial Results

Marker Therapeutics Reports Fiscal Year 2021 Operating and Financial Results

Enrollment of first 20 patients of the Company’s Phase 2 acute myeloid leukemia (AML) trial completed in Q4 2021 Topline readout of Group 2 active disease anticipated in Q2 2022 Company plans to file INDs in lymphoma and pancreatic cancer by year end, with clinical trials to be initiated in 2023 HOUSTON, March 17, 2022 (GLOBE NEWSWIRE) — Marker Therapeutics, Inc. (Nasdaq:MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid tumor indications, today provided a corporate update and reported financial results for the fiscal year ended December 31, 2021. “In 2021, we completed enrollment of the first 20 patients in our Phase 2 AML trial investigating our lead product candidate, MT-401,” said Peter L. Hoang,...

Continue reading

Geekco Appoints Mario Beaulieu as Chief Executive Officer

Geekco Appoints Mario Beaulieu as Chief Executive Officer

LAVAL, Québec, March 17, 2022 (GLOBE NEWSWIRE) — Geekco Technologies Corporation (the “Corporation” or “Geekco”) (TSX-V: GKO; OTCQB: GKOTF), which operates the FlipNpik application within a collaborative ecosystem, within the digital and virtual universe, coupled with blockchain technology, that rewards users who help boost the visibility of neighbourhood businesses by stimulating their online traffic and increasing sales, is pleased to announce the appointment of Mario Beaulieu as Chief Executive Officer. Mr. Beaulieu is both an entrepreneur and an executive. For more than 25 years, he has contributed to the development and commercialization of technology solutions for large companies and SMEs. He has founded and worked with innovative consulting and technology companies that, due to his contribution, have achieved international...

Continue reading

Verisk Issues Statement Regarding D.E. Shaw

Verisk Issues Statement Regarding D.E. Shaw

JERSEY CITY, N.J., March 17, 2022 (GLOBE NEWSWIRE) — Verisk (Nasdaq: VRSK) today issued the following statement regarding the press release issued today by D.E. Shaw: The Verisk board of directors has engaged in a constructive private dialogue with D.E. Shaw since October 2021. During those discussions, there has been broad alignment between D.E. Shaw’s recommendations and initiatives already underway or under consideration by Verisk. The company has valued D.E. Shaw’s input and intends to continue this interaction. Verisk has been engaging in an extensive shareholder outreach program, led by independent members of the board and management, that has provided a range of perspectives from investors, including D.E. Shaw. Informed by this feedback, Verisk has undertaken several actions aimed at advancing corporate governance and enhancing...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.